Role of Oxygenation in Moderate COVID-19 Pneumonia with High Flow Nasal Cannula and Standard Non-Rebreathing Mask: A Comparative Study
DOI:
https://doi.org/10.3329/ssmcj.v31i2.69447Keywords:
COVID-19, Hypoxemia, High Flow Nasal Cannula, Non rebreathing mask, Oxygen Therapy, PneumoniaAbstract
Background: To evaluate the effectiveness of High Flow Nasal Cannula (HFNC) and standard non rebreathing mask (NRBM) as oxygen delivery device, in moderate cases of COVID-19 Pneumonia.
Methods: A single-centre, prospective analysis conducted at KBFGH. Eighty enrolled patients were randomly divided into two groups according to the oxygen delivery device used. Group 1 (n = 40) received HFNC and group 2 (n = 40) received NRBM as initial oxygen delivery device, to maintain a target saturation of e” 96% in both groups. The success rate of oxygen therapy, time to progression to severe disease, PaO2, PaO2/FiO2 ratio, respiratory rate, heart rate, blood pressure, number of patients requiring NIV or endotracheal intubation, time for de-escalation of oxygen therapy to lower Fio2 device and patient satisfaction level were compared among the two groups.
Results: Demographic, clinical variables and treatment given were comparable in the two groups. In the HFNC group 83.3% patients had successful outcomes with the initial oxygen therapy device used as compared to 66.6% in the NRBM group. However, the use of HFNC resulted in improved oxygenation (P < 0.001), better patient satisfaction (P < 0.001) and shorter time for de-escalation of oxygen therapy to a lower FIO2 device (3.75 ± 1.032 vs. 6.83 ± 0.928).
Conclusions: HFNC is a reliable oxygen therapy modality for moderate category COVID- 19 pneumonia that results in better oxygenation and a greater patient satisfaction level as compared to a non-rebreathing mask.
Sir Salimullah Med Coll J 2023; 31: 79-85
49
72
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Prosanjit Mazumder, Chandan Kumar Banik, Ajit Kumar Basak, AZM Saifuddin, AKM Habibullah, Goutam Chandra Ghosh
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.